| scholarly article | Q13442814 |
| P50 | author | Lynne Mofenson | Q43882680 |
| Newton Kumwenda | Q45453026 | ||
| Taha E. Taha | Q55523359 | ||
| Susan Eshleman | Q65971879 | ||
| Jessica M Fogel | Q89772871 | ||
| Allan Taylor | Q99564199 | ||
| P2093 | author name string | Jin Sun | |
| Donald R Hoover | |||
| Mary G Fowler | |||
| P2860 | cites work | Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants | Q33396950 |
| Early Antiretroviral Therapy and Mortality among HIV-Infected Infants | Q34175450 | ||
| Antiretroviral treatment for children with peripartum nevirapine exposure | Q34494986 | ||
| Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero | Q34711999 | ||
| Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission | Q35145366 | ||
| Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial | Q35965722 | ||
| Maternal or infant antiretroviral drugs to reduce HIV-1 transmission | Q36231035 | ||
| Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. | Q36983684 | ||
| In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. | Q37364479 | ||
| Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials | Q38875948 | ||
| Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns | Q38880191 | ||
| Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012. | Q38880584 | ||
| Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. | Q38880827 | ||
| Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). | Q38884920 | ||
| Response to antiretroviral therapy after a single, peripartum dose of nevirapine | Q40799526 | ||
| Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. | Q46534172 | ||
| Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission | Q46558677 | ||
| LigAmp for sensitive detection of single-nucleotide differences. | Q53863271 | ||
| Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine | Q79372692 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nevirapine | Q263713 |
| P304 | page(s) | 911-917 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis | |
| P478 | volume | 25 |
| Q27014960 | Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan Africa |
| Q28546418 | Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique |
| Q36471547 | Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis |
| Q37304975 | Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants |
| Q36580779 | Safety of combination antiretroviral prophylaxis in high-risk HIV-exposed newborns: a retrospective review of the Canadian experience |
| Q37003038 | Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay |
| Q24598653 | Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk |
| Q35902684 | The HIV Epidemic: High-Income Countries. |
Search more.